Influence of pretransplant pregnancy on survival, of renal allografts from living donors

Transplantation

Volumn 72, Issue 2, 2001, Pages 228-232

  Mahanty, Harish D ^a   Cherikh, Wida S ^b   Chang, George J ^a   Baxter Lowe, Lee Ann ^b   Roberts, John P ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c M896 Box 0780 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; DONOR; FEMALE; GRAFT SURVIVAL; HAPLOTYPE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROCHIMERISM; PREGNANCY; PRIORITY JOURNAL; PROGENY;

EID: 0034908847     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200107270-00010     Document Type: Article

References (31)

1. Living donor transplants
2. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation
3. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
4. Is microchimerism needed for allograft tolerance?
5. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens
6. Microchimerism and autoimmune disease
7. Levels of peripheral T cell tolerance induced by different doses of tolerogen
8. Peripheral T cell tolerance
9. Identification of donor hematopoietic progenitor cells after allogenic liver transplantation
10. Murine liver allograft transplantation: Tolerance and donor cell chimerism
11. Role of the graft as a source of donor-type microchimerism in liver transplant patients
12. Microchimerism and the pathogenesis of systemic sclerosis
13. Bone marrow transplantation as a means of inducing tolerance
14. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
15. Planned preimmunization of renal allograft recipients
16. Improvement of kidney-graft survival with increased numbers of blood transfusions
17. Effect of blood transfusions on subsequent kidney transplants
18. Donor-specific transfusion and donor bone marrow infusion in renal transplantation tolerance. A review of efficacy and mechanisms
19. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption
20. High-dose donor bone marrow infusions to enhance allograft survival: The effect of timing
21. Post transplantation donor-specific bone marrow transfusion in polyclonal antilymphocyte serum-treated recipients: The optimal cellular antigen for induction of unresponsiveness to organ allografts
22. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys
23. Three years of follow-up of bone marrow-augmented organ transplant recipients: The impact on donor-specific immune modulation
24. Donor type microchimerism is an infrequent event following liver transplantation and is not associated with graft acceptance
25. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism
26. Donor-recipient microchimerism is not required for tolerance induction following recipient pre-treatment with donor-specific transfusion and anti-CD4 antibody. Evidence of a clear role for short-term antigen persistence
27. Immune mechanisms of acute rejection
28. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation
29. Chimerism in peripheral blood of sensitized patients waiting for renal transplantation
30. Microchimerism in sensitized renal patients